Lazar Popović
Associate Professor
Oncology Institute of Vojvodina, Clinic for Internal Oncology
lazar.popovic@mf.uns.ac.rs
Phone: 0214805418
ORCID ID : 0000-0002-3278-6875
Oncology Institute of Vojvodina, Clinic for Internal Oncology
lazar.popovic@mf.uns.ac.rs
Phone: 0214805418
ORCID ID : 0000-0002-3278-6875
| Academic career | Year | Institution | Field |
|---|---|---|---|
Status Acquired |
2020 |
Faculty of Medicine Novi Sad |
Oncology | PhD |
2014 |
Faculty of Medicine Novi Sad |
Oncology |
Specialization |
2011 |
Faculty of Medicine Novi Sad |
Internal Medicine |
Graduated |
2005 |
Faculty of Medicine Novi Sad |
General Medicine |
| M | Description |
|---|---|
21a | Tan A, Wright G, Thummala A, Danso M, Popovic L, Pluard T et al. Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial Lancet Oncol Lancet Oncol. 2019 Nov;20(11):1587-1601. |
23 | Cvetanovic A, Pejcic I, Zivkovic N, Krtinic D, Kostic M, Popovic L Do we really know how to overcome trastuzumab resistance in hormone sensitive metastatic breast cancer? J BUON. 2019 Mar-Apr;24(2):516-521. |
22 | Popovic LS, Matovina-Brko G, Popovic M, Popovic M, Cvetanovic A, Nikolic I, Kukic B, Petrovic D. Immunotherapy in the treatment of lymphoma. World J Stem Cells. 2021 Jun 26;13(6):503-520.. |
23 | Matovina Brko G, Popovic M, Jovic M, Radic J, Bodlovic Kladar M, Nikolic I, Vidovic V, Kolarov Bjelobrk I, Kukic B, Salma S, Litavski J, Petrovic N, Vranjkovic B, Roganovic T, Ruzic M, Dugandzija T, Popovic L. COVID-19 vaccines and cancer patients: acceptance, attitudes and safety. J BUON. 2021 ;26(5):2183-2190. |
51 | Popović M, Matovina-Brko G, Petrović D, Vranjković B, Radić J , Popović L. Prognostic value of age-adjusted international prognostic index in patients with relapsed or refractory diffuse large B-cell lymphoma- a single centre experience. Med Pregl 2019;LXXII (1-2): 25-29. |
23 | Popovic L, Tomasevic Z, Stamatovic L, Markovic I, Matovina-Brko G, Buta M, Golubovic A, Selakovic V, Trifunovic J, Mutrezani Z, Ivanovic N, Nedovic J, Ninkovic S, Filipovic S, Cvetanovic A, Djordjevic N, Karanikolic A, Ivkovic-Kapic T, Vicko F. Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSE. J BUON. 2018 Mar-Apr;23(2):522-532. |
51 | Popovic M, Popovic M, Matovina-Brko G, Jovic M, Popovic LS. Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma. World J Clin Oncol. 2022 Jan 24;13(1):28-38. |
34 | Popovic M, Matovina-Brko G, Popovic L, Vranjkovic B,Novel target and immunotherapy Options in the Treatment of NHL, 9th French Serbian Oncology Congress, Novi Sad. 16-17 march 2018, p 2-3. |
23 | Cvetanovic A, Filipovic S, Zivkovic N, Popovic L, Kostic M, Djordjevic M, Karanikolic A, Krtinic D. Ten years of using adjuvant trastuzumab in breast cancer in Serbia - Single institution experience. J BUON. 2018 Mar-Apr;23(2):353-360. |
51 | Popovic LS, Matovina-Brko G, Popovic M Checkpoint inhibitors in the treatment of urological malignancies ESMO Open. 2017 Jun 23;2(2):e000165. |
| Course | Studies |
|---|---|
Oncology | Integrated academic studies in medicine |
Nursing care of oncology patient with basics of oncology | Undergraduate academic and applied studies in nursing |
Oncology and basic radiotherapy | Undergraduate applied studies in radiologic technology |
Special radiotherapy | Undergraduate applied studies in radiologic technology |